These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29743405)

  • 1. [Recurrent SPI1 fusions in pediatric T-cell acute lymphoblastic leukemia: novel mutations with poor prognosis].
    Seki M; Takita J
    Rinsho Ketsueki; 2018; 59(4):439-447. PubMed ID: 29743405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.
    Seki M; Kimura S; Isobe T; Yoshida K; Ueno H; Nakajima-Takagi Y; Wang C; Lin L; Kon A; Suzuki H; Shiozawa Y; Kataoka K; Fujii Y; Shiraishi Y; Chiba K; Tanaka H; Shimamura T; Masuda K; Kawamoto H; Ohki K; Kato M; Arakawa Y; Koh K; Hanada R; Moritake H; Akiyama M; Kobayashi R; Deguchi T; Hashii Y; Imamura T; Sato A; Kiyokawa N; Oka A; Hayashi Y; Takagi M; Manabe A; Ohara A; Horibe K; Sanada M; Iwama A; Mano H; Miyano S; Ogawa S; Takita J
    Nat Genet; 2017 Aug; 49(8):1274-1281. PubMed ID: 28671687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic basis of pediatric T-cell acute lymphoblastic leukemia and its clinical impact].
    Takita J
    Rinsho Ketsueki; 2018; 59(7):953-959. PubMed ID: 30078808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
    Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
    Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1.
    Zhu H; Zhang L; Wu Y; Dong B; Guo W; Wang M; Yang L; Fan X; Tang Y; Liu N; Lei X; Wu H
    Elife; 2018 Nov; 7():. PubMed ID: 30412053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells.
    Delestré L; Cui H; Esposito M; Quiveron C; Mylonas E; Penard-Lacronique V; Bischof O; Guillouf C
    Haematologica; 2017 Nov; 102(11):1850-1860. PubMed ID: 28912174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B.
    Batista CR; Lim M; Laramée AS; Abu-Sardanah F; Xu LS; Hossain R; Bell GI; Hess DA; DeKoter RP
    Blood Adv; 2018 Nov; 2(21):2798-2810. PubMed ID: 30355579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dasatinib-therapy induced sustained remission in a child with refractory TCF7-SPI1 T-cell acute lymphoblastic leukemia.
    He Y; Zhang J; Zhang Y; Hu Z; Wang P; Gan W; Xie S; Qian M; Pui CH; Jiang H; Zhu X; Zhang H; Zhang W
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29724. PubMed ID: 35441457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia.
    Rimmelé P; Esposito M; Delestré L; Guervilly JH; Ridinger-Saison M; Despras E; Moreau-Gachelin F; Rosselli F; Guillouf C
    Oncotarget; 2017 Jun; 8(23):37104-37114. PubMed ID: 28415748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13.
    Yu M; Al-Dallal S; Al-Haj L; Panjwani S; McCartney AS; Edwards SM; Manjunath P; Walker C; Awgulewitsch A; Hentges KE
    Genesis; 2016 Oct; 54(10):519-533. PubMed ID: 27506447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic and epigenetic landscape of pediatric T-cell acute lymphoblastic leukemia].
    Kimura S
    Rinsho Ketsueki; 2019; 60(5):459-467. PubMed ID: 31168014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.
    Chen B; Jiang L; Zhong ML; Li JF; Li BS; Peng LJ; Dai YT; Cui BW; Yan TQ; Zhang WN; Weng XQ; Xie YY; Lu J; Ren RB; Chen SN; Hu JD; Wu DP; Chen Z; Tang JY; Huang JY; Mi JQ; Chen SJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):373-378. PubMed ID: 29279377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based targeted RNA sequencing reveals novel disease-related gene fusions in pediatric and adult T-ALL.
    Norvilas R; Batiuskaite R; Dirse V; Semaskeviciene R; Gineikiene E; Stoskus M; Vaitkeviciene G; Rascon J; Griskevicius L
    Leuk Res; 2022 May; 116():106825. PubMed ID: 35339799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia.
    Gregoricchio S; Polit L; Esposito M; Berthelet J; Delestré L; Evanno E; Diop M; Gallais I; Aleth H; Poplineau M; Zwart W; Rosenbauer F; Rodrigues-Lima F; Duprez E; Boeva V; Guillouf C
    Nucleic Acids Res; 2022 Aug; 50(14):7938-7958. PubMed ID: 35871293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric T-cell acute lymphoblastic leukemia.
    Karrman K; Johansson B
    Genes Chromosomes Cancer; 2017 Feb; 56(2):89-116. PubMed ID: 27636224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Precision medicine and molecular target drugs in pediatric hematologic malignancies: acute lymphoblastic leukemia].
    Takita J
    Rinsho Ketsueki; 2020; 61(6):657-664. PubMed ID: 32624540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.